Home > Compound List > Compound details
144035-83-6 molecular structure
click picture or here to close

3-(cyclopentyloxy)-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide

ChemBase ID: 1562
Molecular Formular: C18H18Cl2N2O3
Molecular Mass: 381.25312
Monoisotopic Mass: 380.06944781
SMILES and InChIs

SMILES:
Clc1cncc(Cl)c1NC(=O)c1ccc(OC)c(c1)OC1CCCC1
Canonical SMILES:
COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl
InChI:
InChI=1S/C18H18Cl2N2O3/c1-24-15-7-6-11(8-16(15)25-12-4-2-3-5-12)18(23)22-17-13(19)9-21-10-14(17)20/h6-10,12H,2-5H2,1H3,(H,21,22,23)
InChIKey:
RRRUXBQSQLKHEL-UHFFFAOYSA-N

Cite this record

CBID:1562 http://www.chembase.cn/molecule-1562.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
3-(cyclopentyloxy)-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide
IUPAC Traditional name
piclamilast
Synonyms
RP 73-401
Piclamilast
CAS Number
144035-83-6
PubChem SID
46508612
160965019
PubChem CID
154575
CHEMBL
42126
Chemspider ID
136184
DrugBank ID
EXPT02600
KEGG ID
D05474
Unique Ingredient Identifier
WM58D7C3ZT
Wikipedia Title
Piclamilast

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price

CALCULATED PROPERTIES

CALCULATED PROPERTIES

ALOGPS 2.1 JChem
Solubility (Water) 6.10e-03 g/l  Log P 4.65 
LOG S -4.8 
Acid pKa 8.248247  H Acceptors
H Donor LogD (pH = 5.5) 4.093809 
LogD (pH = 7.4) 4.040309  Log P 4.094907 
Molar Refractivity 98.3838 cm3 Polarizability 37.571217 Å3
Polar Surface Area 60.45 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Bioassay(PubChem)

DETAILS

DETAILS

DrugBank DrugBank Wikipedia Wikipedia
DrugBank - DB01791 external link
Item Information
Drug Groups experimental
Description Piclamilast (RP-73,401), is a selective PDE4 inhibitor. It is comparable to other PDE4 inhibitors for its anti-inflammatory effects. It has been investigated for its applications to the treatment of conditions such as chronic obstructive pulmonary disease, bronchopulmonary dysplasia and asthma. It is a second generation compound that exhibits structural functionalities of the PDE4 inhibitors cilomilast and roflumilast. The structure for piclamilast was first elucidated in a 1995 European patent application.
Affected Organisms
Humans and other mammals
External Links
Wikipedia

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle